CRIB Scores as a Tool for Assessing Risk for the Development of Pulmonary Hypertension in Extremely Preterm Infants with Bronchopulmonary Dysplasia

Abstract

Objective Bronchopulmonary dysplasia (BPD) increases the risk for developing pulmonary hypertension (PH). However, the risk factors associated with BPD-associated PH remain unclear. Our primary aim was to determine perinatal risk factors associated with the development of PH in infants with BPD.

Study Design We retrospectively reviewed medical records of 303 infants born at ≤ 28 weeks' gestation. Infants were categorized as having no, mild, moderate, or severe BPD. PH was diagnosed by echocardiogram. Data were analyzed using Fisher exact test, two-sample t-test, and multivariable logistic regression.

Results The incidence of PH in our cohort was 12%. Infants with PH had lower birth weights and gestational ages (p < 0.001). After controlling for confounding variables, severe BPD (p < 0.001), and higher Clinical Risk Index for Babies (CRIB) scores (p = 0.04) were associated with the development of PH.

Conclusion Severe BPD increases the risk for developing PH. Higher CRIB scores correlate with PH development in infants with BPD. We speculate that CRIB scores may allow for early categorization of preterm infants with a higher likelihood of developing PH.

Keywords

neonatal - bronchopulmonary dysplasia - pulmonary hypertension

• References

• 1 Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163 (7) 1723-1729
• 2 Dammann O, Leviton A, Bartels DB, Dammann CE. Lung and brain damage in preterm newborns. Are they related? How? Why?. Biol Neonate 2004; 85 (4) 305-313
• 3 Dishop MK. Paediatric interstitial lung disease: classification and definitions. Paediatr Respir Rev 2011; 12 (4) 230-237
• 4 Doyle LW, Faber B, Callanan C, Freezer N, Ford GW, Davis NM. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 2006; 118 (1) 108-113
• 5 O'Shea TM. Cerebral palsy in very preterm infants: new epidemiological insights. Ment Retard Dev Disabil Res Rev 2002; 8 (3) 135-145
• 6 Kim GB. Pulmonary hypertension in infants with bronchopulmonary dysplasia. Korean J Pediatr 2010; 53 (6) 688-693
• 7 An HS, Bae EJ, Kim GB , et al. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 2010; 40 (3) 131-136
• 8 Chen S, Rong M, Platteau A , et al. CTGF disrupts alveolarization and induces pulmonary hypertension in neonatal mice: implication in the pathogenesis of severe bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2011; 300 (3) L330-L340
• 9 Durmowicz AG, Orton EC, Stenmark KR. Progressive loss of vasodilator responsive component of pulmonary hypertension in neonatal calves exposed to 4,570 m. Am J Physiol 1993; 265 (6 Pt 2) H2175-H2183
• 10 Khemani E, McElhinney DB, Rhein L , et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007; 120 (6) 1260-1269
• 11 Haworth SG. Pulmonary hypertension in childhood. Eur Respir J 1993; 6 (7) 1037-1043
• 12 Kulik TJ, Rhein LM, Mullen MP. Pulmonary arterial hypertension in infants with chronic lung disease: will we ever understand it?. J Pediatr 2010; 157 (2) 186-190
• 13 Farquhar M, Fitzgerald DA. Pulmonary hypertension in chronic neonatal lung disease. Paediatr Respir Rev 2010; 11 (3) 149-153
• 14 Fike CD, Slaughter JC, Kaplowitz MR, Zhang Y, Aschner JL. Reactive oxygen species from NADPH oxidase contribute to altered pulmonary vascular responses in piglets with chronic hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2008; 295 (5) L881-L888
• 15 Polglase GR, Hooper SB, Gill AW , et al. Intrauterine inflammation causes pulmonary hypertension and cardiovascular sequelae in preterm lambs. J Appl Physiol (1985) 2010; 108 (6) 1757-1765
• 16 Alexander GR, Kogan MD, Himes JH, Mor JM, Goldenberg R. Racial differences in birthweight for gestational age and infant mortality in extremely-low-risk US populations. Paediatr Perinat Epidemiol 1999; 13 (2) 205-217
• 17 Check J, Gotteiner N, Liu X , et al. Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia. J Perinatol 2013; 33 (7) 553-557
• 18 Jelliffe-Pawlowski LL, Shaw GM, Stevenson DK , et al. Risk of bronchopulmonary dysplasia by second-trimester maternal serum levels of α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Pediatr Res 2012; 71 (4 Pt 1) 399-406
• 19 McLaughlin VV, Archer SL, Badesch DB , et al; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53 (17) 1573-1619
• 20 Steinhorn RH. Diagnosis and treatment of pulmonary hypertension in infancy. Early Hum Dev 2013; 89 (11) 865-874
• 21 Subhedar NV. Recent advances in diagnosis and management of pulmonary hypertension in chronic lung disease. Acta Paediatr Suppl 2004; 93 (444) 29-32
• 22 Bhat R, Salas AA, Foster C, Carlo WA, Ambalavanan N. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics 2012; 129 (3) e682-e689
• 23 Ehrenkranz RA, Walsh MC, Vohr BR , et al; National Institutes of Child Health and Human Development Neonatal Research Network. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116 (6) 1353-1360
• 24 Galiè N, Hoeper MM, Humbert M , et al; ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30 (20) 2493-2537
• 25 Ahmed S, Siddiqui AK, Sadiq A, Shahid RK, Patel DV, Russo LA. Echocardiographic abnormalities in sickle cell disease. Am J Hematol 2004; 76 (3) 195-198
• 26 Nauser TD, Stites SW. Diagnosis and treatment of pulmonary hypertension. Am Fam Physician 2001; 63 (9) 1789-1798
• 27 Gagliardi L, Cavazza A, Brunelli A , et al. Assessing mortality risk in very low birthweight infants: a comparison of CRIB, CRIB-II, and SNAPPE-II. Arch Dis Child Fetal Neonatal Ed 2004; 89 (5) F419-F422
• 28 Meau-Petit V, Thouvenin G, Guillemot-Lambert N , et al. Bronchopulmonary dysplasia-associated pulmonary arterial hypertension of very preterm infants [in French]. Arch Pediatr 2013; 20 (1) 44-53
• 29 Stenmark KR, Abman SH. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol 2005; 67: 623-661
• 30 Parker TA, Abman SH. The pulmonary circulation in bronchopulmonary dysplasia. Semin Neonatol 2003; 8 (1) 51-61
• 31 de Courcy-Wheeler RH, Wolfe CDA, Fitzgerald A, Spencer M, Goodman JD, Gamsu HR. Use of the CRIB (clinical risk index for babies) score in prediction of neonatal mortality and morbidity. Arch Dis Child Fetal Neonatal Ed 1995; 73 (1) F32-F36
• 32 Dammann O, Naples M, Bednarek F , et al; ELGAN Study Investigators. SNAP-II and SNAPPE-II and the risk of structural and functional brain disorders in extremely low gestational age newborns: the ELGAN study. Neonatology 2010; 97 (2) 71-82
• 33 Patrick SW, Schumacher RE, Davis MM. Methods of mortality risk adjustment in the NICU: a 20-year review. Pediatrics 2013; 131 (Suppl. 01) S68-S74
• 34 Rautonen J, Mäkelä A, Boyd H, Apajasalo M, Pohjavuori M. CRIB and SNAP: assessing the risk of death for preterm neonates. Lancet 1994; 343 (8908) 1272-1273
• 35 Li Y, Yan J, Li M , et al. Addition of SNAP to perinatal risk factors improves the prediction of bronchopulmonary dysplasia or death in critically ill preterm infants. BMC Pediatr 2013; 13 (138) 138